| Literature DB >> 28215646 |
Sergio Zavala-Vega1, Graciela Castro-Escarpulli2, Hector Hernández-Santos3, Citlatepetl Salinas-Lara4, Icela Palma5, Juan Manuel Mejía-Aranguré6, Noemí Gelista-Herrera4, Daniel Rembao-Bojorquez4, Sara A Ochoa7, Ariadnna Cruz-Córdova7, Juan Xicohtencatl-Cortes7, Gabriel Uribe-Gutiérrez3, José Arellano-Galindo8.
Abstract
Several risk factors are involved in glioblastoma, including cytomegalovirus (CMV). This research was carried out to determine the rate of CMV infection, as well as HSV 1/2 and EBV in brain tissue, in patients with glioblastomamultiforme (GBM). The tissues were tested using immunohistochemistry, PCR, in situ hybridization and real-time PCR. At least, one HHV was detected in 21/29 (72%) patients as follows: single infections with HSV-1/2 in 4/21 (19%), EBV in 6/21 (28.6%) and CMV in 1/21 (4.8%). Mixed viral infection, HSV-1/2 and EBV were detected in 4/21 patients (19%), CMV and EBV in 5/21 (23.8%), and HSV-1/2, EBV, and CMV in 1/21. The CMV viral load ranged from 3×102 to 4.33×105 genome/100ng of tissue. Genotype based on CMV gB was 3/7 where 2/3 was gB1 and 1/3 gB4. HSV, EBV and CMV were frequently found in brain tissues, more in mix in a population reported as highly seropositive.Entities:
Keywords: Cytomegalovirus; Epstein–Barr; Glioblastomamultiforme; HHVs; Herpes; Viral infection
Mesh:
Year: 2016 PMID: 28215646 DOI: 10.1016/j.prp.2016.12.006
Source DB: PubMed Journal: Pathol Res Pract ISSN: 0344-0338 Impact factor: 3.250